Previous Article | Next Article ![]()
Infect Immun, June 1998, p. 3012-3016, Vol. 66, No. 6
Department of Microbiology and Immunology,
Albert Einstein College of Medicine, Bronx, New York 10461
Received 31 October 1997/Returned for modification 6 January
1998/Accepted 27 March 1998
Nitric oxide (NO) generated by gamma interferon (IFN- Shigella spp. are the
primary cause of bacillary dysentery worldwide (14).
Pathogenic Shigella flexneri induces host cell uptake
and escape from the endocytic vacuole into the cytoplasm, where
cell-to-cell spread of bacteria is mediated through recruitment of host cell actin. In vitro, both macrophage and epithelial cell lines
can be infected with S. flexneri. Infected mouse and
human macrophage cells and HeLa cells foster intracellular replication and eventually die by apoptosis, oncosis, or necrosis (9, 19, 32). We have recently demonstrated that gamma interferon
(IFN- Nitric oxide (NO) and other reactive nitrogen intermediates (RNIs) are
the primary mediators of host cell defense against many intracellular
and extracellular bacterial, parasitic, and fungal pathogens (8,
13, 17). Experiments implicating NO and RNIs in killing have
largely been based on three complementary approaches. First, many
pathogens, including Mycobacterium tuberculosis and
Salmonella typhimurium, are susceptible to NO generated in cell-free systems (3, 5, 24). Second, inhibitors of nitric oxide synthase (NOS) inhibit activated cell killing of M. tuberculosis, Listeria monocytogenes, or S. typhimurium in vitro (1, 3, 28) and increase the
susceptibility of mice to these same pathogens (2, 4, 5).
Finally, mice with a targeted deletion in the inducible NOS gene
(NOS2) demonstrate increased susceptibility to infection
with M. tuberculosis, L. monocytogenes,
Toxoplasma gondii, or Leishmania major (15,
16, 26, 31). In this report, we examine the contribution of NO or
other RNIs in mediating killing of S. flexneri during
infection.
Under acidic conditions, NO and other RNIs can be generated from
nitrite through a nitrous acid intermediate (27). To test whether NO generated in cell-free systems can exert bactericidal effects on S. flexneri, bacterial survival was measured
in tryptic soy broth, at pH 4.5, 5.0, or 5.5, supplemented with sodium
nitrite to final concentrations of 1 to 10 mM (Fig.
1). At pH 4.5 and 5.0, increasing
bactericidal effects were observed with increasing nitrite
concentrations, while no significant killing was observed at pH 5.5 at
any nitrite concentration. Furthermore, no killing was observed at any
pH without the addition of nitrite, demonstrating that the killing
observed at pH 4.5 and 5.0 was not due solely to lower pH.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Clearance of Shigella flexneri Infection
Occurs through a Nitric Oxide-Independent Mechanism
![]()
ABSTRACT
Top
Abstract
Text
References
)
activation of macrophages mediates the killing of many intracellular pathogens. IFN-
is essential to innate resistance to Shigella flexneri infection. We demonstrate that NO is produced following S. flexneri infection both in mice and in activated
cells in vitro and that while it is able to kill S. flexneri in a cell-free system, it is not required for clearance
of S. flexneri in either infected mice or in activated
cells in vitro.
![]()
TEXT
Top
Abstract
Text
References
) activation of macrophage or fibroblast cells induces host
cell killing of intracellular S. flexneri
(30), although the specific IFN-
-induced mediators
responsible for killing remain undefined.

View larger version (17K):
[in a new window]
FIG. 1.
Numbers of viable wild-type S. flexneri
strain 2457T organisms after 2 h of incubation in different
concentrations of sodium nitrite in tryptic soy broth at pH 4.5 (squares), 5.0 (circles), or 5.5 (triangles). Each data point
represents the mean of three independent determinations. Error bars,
±1 standard deviation. Where error bars are not seen, the error bar
was smaller than the symbol.
IFN-
in combination with either tumor necrosis factor alpha or
lipopolysaccharide (LPS) has been shown to maximally stimulate NO
production in mouse macrophages (3, 6). To define optimal concentrations for the production of NO in J774 and L2 cells, levels of
nitrite (a stable end product of NO production) were assayed for the
culture supernatants of cells treated overnight with medium containing
no additive, recombinant mouse (J774 cells) or rat (L2 cells) IFN-
(100 U/ml), LPS (1 µg/ml), or a combination of these factors. Only
baseline levels of nitrite were found for J774 cells or L2 fibroblast
cells not activated or activated with IFN-
(100 U/ml) alone (Table
1). J774 cells activated overnight with
IFN-
and LPS produced 31.3 ± 12.5 µM (mean ± standard
deviation) nitrite; increased nitrite concentrations were completely
inhibited with aminoguanidine (2 mM). L2 cell monolayers activated in
the same manner failed to produced nitrite after activation overnight or for 48 h (Table 1).
|
Levels of nitrite were also measured for the culture supernatants of
J774 macrophage cells, bone marrow macrophages derived from either
C57BL/6 or NOS2
/
mice, and L2 cells that
had been infected with S. flexneri.
NOS2
/
mice used in this study were derived
in a 129Sv × C57BL/6 mixed background and had been
backcrossed into C57BL/6 for five to six generations. Since 129Sv
mice, C57BL/6 mice, and F2 129Sv × C57BL/6 mice have
identical susceptibilities to infection with S. flexneri (data presented below), macrophages harvested from the
bone marrow of C57BL/6 mice were used as controls in experiments
involving macrophages harvested from the bone marrow of
NOS2
/
mice. J774 macrophage cells were
seeded at 5.0 × 105 cells/well in 24-well plates,
bone marrow macrophages were seeded at 2.2 × 105 to
2.4 × 105 cells/well in 48-well plates, and L2
fibroblast cells were grown as monolayers in 35-mm-diameter dishes. For
J774 macrophage cells and bone marrow macrophages, S. flexneri infections were performed at a multiplicity of infection
of 1.0, as described previously (30). For L2 fibroblast
cells, S. flexneri infections were performed at a
multiplicity of infection of 0.05 to 0.1. Following infection with
S. flexneri, increases in nitrite concentrations were
consistently observed for IFN-
-activated J774 macrophage cells and
bone marrow macrophages from C57BL/6 mice but not for
IFN-
-activated L2 fibroblast cells or bone marrow macrophages
derived from NOS2
/
mice (Table
2). The increases in NO production that
occurred following S. flexneri infection of
IFN-
-activated J774 cells were completely inhibited by addition of
the NOS inhibitor aminoguanidine (2 mM) (Table 2). In the absence of
IFN-
activation, no increases in nitrite concentration were observed
for any cell type (Table 2).
|
To assess whether NO and RNIs mediate the observed decreased
intracellular survival of S. flexneri in
IFN-
-activated macrophages and fibroblast cells and the suppression
of plaque formation by S. flexneri in fibroblast cells
(30), we tested the effects of the NOS inhibitor
aminoguanidine on killing of intracellular bacteria and bacterial
plaque formation in S. flexneri-infected cells, as
previously described (21, 30). J774 cells were activated with IFN-
alone or IFN-
and LPS (1 µg/ml), with and without aminoguanidine (2 mM), and infected 16 h later with the
S. flexneri wild-type strain 2457T at a multiplicity of
infection of 1.0. At either 2.5 or 4.5 h following infection,
significantly lower numbers of intracellular S. flexneri were recovered from IFN-
-activated cells than from
cells not activated (Fig.
2A). Despite
significant reductions in nitrite production in the presence of
aminoguanidine (Table 2), no differences were observed in S. flexneri intracellular survival with or without aminoguanidine
(Fig. 2A). In macrophage cells, measurements of S. flexneri intracellular survival were extended for only up to 4.5 to 5.0 h postinfection since maximal Shigella-induced
cell death occurs between 3 and 4 h postinfection (32).
We have previously shown that IFN-
activation of L2 cells prevents
the formation of plaques by S. flexneri
(30). Treatment of IFN-
-activated cells with
aminoguanidine did not restore S. flexneri plaque
formation (data not shown).
|
S. flexneri is able to escape from the phagocytic
vacuole into the cell cytoplasm (11, 25, 32, 33). Lysis of
the phagocytic vacuole is mediated by the ipaB gene product
(11). To determine whether the observed cellular
NO-independent killing of wild-type S. flexneri was
dependent upon bacterial escape into the cell cytoplasm, we evaluated
the role of NO in killing of ipaB S. flexneri SF620
(20). Killing of intracellular ipaB S. flexneri in IFN-
-activated J774 cells was also independent of
NO production (Fig. 2B). Of note, IFN-
-activated cellular killing of
strain SF620 was less efficient than that of wild-type S. flexneri. This suggests that IFN-
-activated mediators are more
efficient in killing intracytoplasmic S. flexneri than
intravacuolar S. flexneri.
Mice with a targeted deletion in the NOS2 gene offer a
complementary approach for the analysis of the contribution of NO in host defense against pathogens (15, 23, 31). The survival of
intracellular S. flexneri over time was determined in
bone marrow macrophages derived from either
NOS2
/
(genetic background described above)
or C57BL/6 mice. Primary macrophages were seeded at 2.2 × 105 to 2.4 × 105 cells/well in 48-well
plates and infected with S. flexneri at a multiplicity
of infection of 1.0, as previously described (30). The same
induction of S. flexneri killing by IFN-
was
observed in cells derived from NOS2
/
mice as
in cells derived from C57BL/6 mice (Fig. 2C).
We have previously used a murine bronchopulmonary model of
S. flexneri infection (18, 29) to assess the
susceptibilities of mice with targeted deletions in specific aspects of
the immune system (30). In this model, the lethal dose of
S. flexneri for mice deficient in IFN-
is at least 5 orders of magnitude less than that for immunocompetent mice,
demonstrating an essential role for this cytokine in innate immunity
(30). NO production in mice can be assessed by measuring the
serum concentration of nitrite plus the more stable end product,
nitrate (15). The concentration of nitrite plus nitrate in
sera from C57BL/6 mice 24 h following intranasal infection
with 107 S. flexneri organisms is 1.9-fold
greater than that in sera drawn prior to infection (P = 0.004) (Table 3). In contrast, the
concentration of nitrite plus nitrate in sera did not increase
following S. flexneri infection in
NOS2
/
mice (Table 3).
|
To assess the contribution of NO to the killing of S. flexneri in vivo, we examined the susceptibility of mice fed 2.5% aminoguanidine in drinking water, a dose previously demonstrated to markedly increase the susceptibility of mice to infection with M. tuberculosis or S. typhimurium (4, 5). Drinking water for groups of six C57BL/6 mice were supplemented or not supplemented with aminoguanidine for 1 week prior to challenge with 106 or 107 S. flexneri organisms and throughout the time course of infection (4). The lethal dose of S. flexneri for C57BL/6 mice has been previously shown to be 107 bacteria (30). No differences in lethal dose or time to death following infection were observed between aminoguanidine-treated mice and untreated control mice (Fig. 3A).
|
To further assess whether in vivo resistance to S. flexneri is an NO-independent process, the susceptibility of
NOS2
/
mice to intranasal S. flexneri infection was examined. Groups of five to nine
NOS2
/
, F2 129Sv × C57BL/6, 129Sv,
and C57BL/6 mice were infected with either 106 or
107 S. flexneri organisms. No differences
in lethal dose or time to death following infection were observed among
these mouse strains (Fig. 3B) (30).
In conclusion, these data demonstrate that S. flexneri
is sensitive to NO generated in cell-free conditions, yet both the killing of S. flexneri in infected cells in vitro and
the resistance of mice are NO-independent processes. This independence
from cellular NO-mediated killing is unusual for intracellular
pathogens and has only recently been described for other pathogens
under specific experimental conditions. For example, for some clinical
isolates of M. tuberculosis, NOS inhibitors did not
significantly reverse the effects of activated macrophage cell killing
(24); for Chlamydia trachomatis,
NOS2
/
mice and mice treated with NOS
inhibitors demonstrated no difference in ability to clear infection
(23); following Mycobacterium avium infection,
immunocompetent and NOS2
/
mice demonstrate
the same susceptibilities to infection (7); and for T. gondii, NO is not required to control acute murine infections but
is essential for the prevention of persistent infection (26).
Due to the intrinsic limitations of infections in vitro and in the mouse bronchopulmonary model, we cannot rule out the possibility that NO contributes to killing of S. flexneri in intestinal infections. Of note, during human intestinal infection with Shigella, the expression of inducible NOS has been shown to increase in the rectal mucosa (12).
Data presented here suggest that for S. flexneri
infection, either (i) IFN-
-activated mediators other than NO or
other RNIs are responsible for clearance of the organism or (ii) the
mechanisms of S. flexneri resistance to NO are
activated only after cellular invasion. The observation that
S. flexneri with disruption of the superoxide dismutase
gene (sodB) is attenuated in both in vitro and in vivo
infection assays suggests that reactive oxygen intermediates may
contribute to bacterial clearance during infection (10).
However, since reactive oxygen intermediates react with RNIs to form
compounds with more potent antibacterial activity (8, 22),
this observation does not rule out a role for RNIs in the clearance of
S. flexneri. If the mechanism of resistance of
intracellular S. flexneri to NO is one that is
activated only after cellular invasion, it might involve enhanced
scavenging by low-molecular-weight thiols (e.g., glutathione or
homocysteine), up-regulation of repair enzymes following injury induced
by RNIs (e.g., RecBCD exonuclease or endonuclease IV), reduction of
intracellular peroxynitrite formation though the superoxide dismutases
(e.g., SodA or SodC) (8), or as-yet-undescribed
factors. Moreover, identification of the cellular mediators responsible
for killing intracellular S. flexneri will
require further study.
| |
ACKNOWLEDGMENTS |
|---|
We are indebted to J. Chan, L. Weiss, A. Sikora, and J. McKinney for helpful discussions and critical review of this
manuscript; J. Stamler and F. Fang for useful advice; J. Mudgett, C. Nathan, and L. Weiss for providing NOS2
/
mice; and A. Zychlinsky for providing S. flexneri
SF620.
This work was supported by NIH grants T32 GM07288 (S.S.W.) and AI35817 (M.B.G.), a Pew Scholars Award in the Biomedical Sciences (M.B.G.), and Established Investigator (M.B.G.) and Grant-in-Aid (M.B.G.) Awards from the American Heart Association.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology and Immunology, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10461. Phone: (718) 430-2118. Fax: (718) 430-8711. E-mail: mgoldber{at}aecom.yu.edu.
Editor: J. R. McGhee
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Beckerman, K. P., H. W. Rogers, J. A. Corbett, R. D. Schreiber, M. L. McDaniel, and E. R. Unanue. 1993. Release of nitric oxide during the T cell-independent pathway of macrophage activation. J. Immunol. 150:888-895[Abstract]. |
| 2. |
Boockvar, K. S.,
D. L. Granger,
R. M. Poston,
M. Maybodi,
M. K. Washington,
J. B. Hibbs, Jr., and R. L. Kurlander.
1994.
Nitric oxide produced during murine listeriosis is protective.
Infect. Immun.
62:1089-1100 |
| 3. |
Chan, J.,
Y. Xing,
R. S. Magliozzo, and B. R. Bloom.
1992.
Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages.
J. Exp. Med.
175:1111-1122 |
| 4. | Chan, J., K. Tanaka, D. Carroll, J. Flynn, and B. R. Bloom. 1995. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect. Immun. 63:736-740[Abstract]. |
| 5. | De Groote, M. A., T. Testerman, Y. Xu, G. Stauffer, and F. C. Fang. 1996. Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium. Science 272:414-417[Abstract]. |
| 6. | Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J. Immunol. 141:2407-2412[Abstract]. |
| 7. | Doherty, T. M., and A. Sher. 1997. Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection. J. Immunol. 158:4822-4831[Abstract]. |
| 8. | Fang, F. C. 1997. Mechanisms of nitric-oxide-related antimicrobial activity. J. Clin. Invest. 99:2818-2825[Medline]. |
| 9. | Fernandez-Prada, C. M., D. L. Hoover, B. D. Tall, and M. M. Venkatesan. 1997. Human monocyte-derived macrophages infected with virulent Shigella flexneri in vitro undergo a rapid cytolytic event similar to oncosis but not apoptosis. Infect. Immun. 65:1486-1496[Abstract]. |
| 10. |
Franzon, V. L.,
J. Arondel, and P. J. Sansonetti.
1990.
Contribution of superoxide dismutase and catalase activities to Shigella flexneri pathogenesis.
Infect. Immun.
58:529-535 |
| 11. | High, N., J. Mounier, M. C. Prevost, and P. J. Sansonetti. 1992. IpaB of Shigella flexneri causes entry into epithelial cells and escape from the phagocytic vacuole. EMBO J. 11:1991-1999[Medline]. |
| 12. | Islam, D., B. Veress, P. K. Bardhan, A. A. Lindberg, and B. Christensson. 1997. In situ characterization of inflammatory responses in the rectal mucosae of patients with shigellosis. Infect. Immun. 65:739-749[Abstract]. |
| 13. |
James, S. L.
1995.
Role of nitric oxide in parasitic infections.
Microbiol. Rev.
59:533-547 |
| 14. | Katz, S. 1986. In New vaccine development establishing priorities: diseases of importance in developing countries. National Academy Press, Washington, D.C. |
| 15. | MacMicking, J. D., C. Nathan, G. Hom, N. Chartrain, D. S. Fletcher, M. Trumbauer, K. Stevens, Q. Xie, K. Sokol, N. Hutchinson, H. Chen, and J. S. Mudgett. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641-650[Medline]. |
| 16. |
MacMicking, J. D.,
R. J. North,
R. LaCourse,
J. S. Mudgett,
S. K. Shah, and C. F. Nathan.
1997.
Identification of nitric oxide synthase as a protective locus against tuberculosis.
Proc. Natl. Acad. Sci. USA
94:5243-5248 |
| 17. | MacMicking, J. D., Q. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323-350[Medline]. |
| 18. | Mallet, C., L. VanDeVerg, H. Collins, and T. Hale. 1993. Evaluation of Shigella vaccine safety and efficacy in an intranasal challenged mouse model. Vaccine 11:190-196[Medline]. |
| 19. | Mantis, N., M. C. Prevost, and P. J. Sansonetti. 1996. Analysis of epithelial cell stress response during infection by Shigella flexneri. Infect. Immun. 64:2474-2482[Abstract]. |
| 20. |
Menard, R.,
P. J. Sansonetti, and C. Parsot.
1993.
Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells.
J. Bacteriol.
175:5899-5906 |
| 21. |
Oaks, E. V.,
M. E. Wingfield, and S. B. Formal.
1985.
Plaque formation by virulent Shigella flexneri.
Infect. Immun.
48:124-129 |
| 22. |
Pacelli, R.,
D. A. Wink,
J. A. Cook,
M. C. Krishna,
W. DeGraff,
N. Friedman,
M. Tsokos,
A. Samuni, and J. B. Mitchell.
1995.
Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli.
J. Exp. Med.
182:1469-1479 |
| 23. |
Ramsey, K. H.,
G. S. Miranpuri,
C. E. Poulsen,
N. B. Marthakis,
L. M. Braune, and G. I. Bryne.
1998.
Inducible nitric oxide synthase does not affect resolution of murine chlamydial genital tract infections or eradication of chlamydiae in primary murine cell culture.
Infect. Immun.
66:835-838 |
| 24. | Rhoades, E. R., and I. M. Orme. 1997. Susceptibility of a panel of virulent strains of Mycobacterium tuberculosis to reactive nitrogen intermediates. Infect. Immun. 65:1189-1195[Abstract]. |
| 25. |
Sansonetti, P. J.,
A. Ryter,
P. Clerc,
A. T. Maurelli, and J. Mounier.
1986.
Multiplication of Shigella flexneri within HeLa cells: lysis of the phagocytic vacuole and plasmid-mediated contact hemolysis.
Infect. Immun.
51:461-469 |
| 26. |
Scharton-Kersten, T. M.,
G. Yap,
J. Magma, and A. Sher.
1997.
Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii.
J. Exp. Med.
185:1261-1273 |
| 27. |
Stuehr, D. J., and C. F. Nathan.
1989.
Nitric oxide. A macrophage product responsible for the cytostasis and respiratory inhibition in tumor target cells.
J. Exp. Med.
169:1543-1555 |
| 28. | Umezawa, K., T. Akaike, S. Fujii, M. Suga, K. Setoguchi, A. Ozawa, and H. Maeda. 1997. Induction of nitric oxide synthesis and xanthine oxidase and their roles in the antimicrobial mechanism against Salmonella typhimurium infection in mice. Infect. Immun. 65:2932-2940[Abstract]. |
| 29. | Van De Verg, L. L., C. Mallet, H. H. Collins, T. Larsen, C. Hammack, and T. L. Hale. 1995. Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection. Infect. Immun. 63:1947-1954[Abstract]. |
| 30. |
Way, S. S.,
A. C. Borczuk,
R. Dominitz, and M. B. Goldberg.
1998.
An essential role for gamma interferon in innate resistance to Shigella flexneri infection.
Infect. Immun.
66:1342-1348 |
| 31. | Wei, X., I. G. Charles, A. Smith, J. Ure, G. Feng, F. Huang, D. Xu, W. Muller, S. Moncada, and F. Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408-411[Medline]. |
| 32. | Zychlinsky, A., M. C. Prevost, and P. J. Sansonetti. 1992. Shigella flexneri induces apoptosis in infected macrophages. Nature 358:167-169[Medline]. |
| 33. | Zychlinsky, A., B. Kenny, R. Menard, M. C. Prevost, I. B. Holland, and P. J. Sansonetti. 1994. IpaB mediates macrophage apoptosis induced by Shigella flexneri. Mol. Microbiol. 11:619-627[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»